CN113940422A - Dietetic composition for preventing and regulating physiological function imbalance of men - Google Patents
Dietetic composition for preventing and regulating physiological function imbalance of men Download PDFInfo
- Publication number
- CN113940422A CN113940422A CN202010691077.3A CN202010691077A CN113940422A CN 113940422 A CN113940422 A CN 113940422A CN 202010691077 A CN202010691077 A CN 202010691077A CN 113940422 A CN113940422 A CN 113940422A
- Authority
- CN
- China
- Prior art keywords
- percent
- powder
- agent
- thermophilic
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 230000035790 physiological processes and functions Effects 0.000 title claims abstract description 13
- 235000005911 diet Nutrition 0.000 title claims abstract description 10
- 230000000378 dietary effect Effects 0.000 title claims abstract description 10
- 230000001105 regulatory effect Effects 0.000 title claims description 7
- 239000000843 powder Substances 0.000 claims abstract description 44
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- 241000208340 Araliaceae Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 11
- 241000237502 Ostreidae Species 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 235000020636 oyster Nutrition 0.000 claims abstract description 11
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 10
- 241000194017 Streptococcus Species 0.000 claims abstract description 10
- 239000008101 lactose Substances 0.000 claims abstract description 9
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 8
- 229930064664 L-arginine Natural products 0.000 claims abstract description 8
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 7
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 7
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 7
- 239000004310 lactic acid Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241000255789 Bombyx mori Species 0.000 claims abstract description 4
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 4
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 4
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 6
- 238000003825 pressing Methods 0.000 claims description 4
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 3
- 240000002319 Citrus sinensis Species 0.000 claims description 3
- 241000190633 Cordyceps Species 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 244000241838 Lycium barbarum Species 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 235000015468 Lycium chinense Nutrition 0.000 claims description 3
- 244000182216 Mimusops elengi Species 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000011265 semifinished product Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- NTNWOCRCBQPEKQ-YFKPBYRVSA-N N(omega)-methyl-L-arginine Chemical compound CN=C(N)NCCC[C@H](N)C(O)=O NTNWOCRCBQPEKQ-YFKPBYRVSA-N 0.000 claims description 2
- 235000007882 dietary composition Nutrition 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 6
- 238000002560 therapeutic procedure Methods 0.000 abstract description 6
- 235000009508 confectionery Nutrition 0.000 abstract description 5
- 238000004090 dissolution Methods 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 230000002035 prolonged effect Effects 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 240000002624 Mespilus germanica Species 0.000 abstract 1
- 238000000034 method Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a dietary therapy composition for preventing and adjusting male physiological function imbalance, belongs to the technical field of traditional Chinese medicines, and particularly relates to a dietary therapy composition for preventing and adjusting male physiological function imbalance. Is prepared from the following raw materials in percentage by weight: 18 to 30 percent of lactose, 3 to 8 percent of oyster peptide, 1 to 4 percent of L-arginine, 1 to 3 percent of ginseng powder, 8 to 15 percent of male silkworm chrysalis peptide powder, 1 to 3 percent of cordyceps militaris powder, 1 to 3 percent of yellow refined powder, 1 to 3 percent of medlar powder, 0.1 to 0.3 percent of thermophilic lactic acid bacillus agent, 0.1 to 0.3 percent of bifidobacterium agent and 0.1 to 0.3 percent of thermophilic streptococcus agent; the ginseng oyster peptide tabletted candy obtained by the invention has the characteristics of convenient preparation, easy acceptance by users, convenient carrying, storage and transportation, feasible preparation process and suitability for large-scale production, the prepared product is a tablet, the appearance is complete and smooth, the color is uniform, the tablet has better uniformity and higher dissolution rate, and simultaneously compared with the existing production process, the service life of a punch of each tablet press is prolonged by 6 months under the same yield, and the production cost of an enterprise is reduced.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a dietary therapy composition for preventing and adjusting physiological function imbalance of men.
Background
As men age, after the age of forty, the body develops various symptoms such as: the symptoms are all caused by the imbalance of the physiological functions of the male, so that a lot of medicines for the imbalance of the physiological functions are used at present, but the medicines are toxic in three parts, and the unexpected risk is caused to the human body after long-term use of the medicines. Therefore, people need to research and develop a food therapy food, and new functional food is prepared from materials with homology of medicine and food, so that the food therapy food has a great effect on improving the physiological function imbalance of men, and the selection variety of market consumers is increased.
Disclosure of Invention
The invention aims to provide a dietetic therapy composition for preventing and regulating physiological function imbalance of men.
The technical scheme provided by the invention is as follows: a dietetic composition for preventing and regulating physiological function imbalance of men is prepared from the following raw materials in parts by weight:
18 to 30 percent of lactose, 3 to 8 percent of oyster peptide, 1 to 4 percent of L-arginine, 1 to 3 percent of ginseng powder, 8 to 15 percent of male silkworm chrysalis peptide powder, 1 to 3 percent of cordyceps militaris powder, 1 to 3 percent of yellow refined powder, 1 to 3 percent of medlar powder, 0.1 to 0.3 percent of thermophilic lactic acid bacillus agent, 0.1 to 0.3 percent of bifidobacterium agent and 0.1 to 0.3 percent of thermophilic streptococcus agent;
in the technical scheme, the milk sugar is 25%, the oyster peptide is 5%, the L-arginine is 3%, the ginseng powder is 2%, the wolfberry fruit powder is 10%, the cordyceps militaris powder is 2%, the sealwort is 2%, the thermophilic lactic acid bacillus agent is 0.2%, the bifidobacterium agent is 0.1%, and the thermophilic streptococcus agent is 0.3%.
The manufacturing steps are as follows:
q1, mixing Concha Ostreae peptide, L-arginine, Ginseng radix powder, fructus Lycii powder, Cordyceps powder, and rhizoma Polygonati powder to obtain mixture;
q2 and lactose are dissolved in purified water, thermophilic lactobacillus, bifidobacterium and streptococcus are added in the environment of 30-36 ℃, the mixture is fermented in a sealed way for 1 month, the PH value of the fermented mixture is 3-3.5, and the mixture is added to prepare soft material with proper humidity;
q3, pressing the soft material through a 14-mesh screen to prepare wet granules;
q4, preparing wet granules, drying at 70 ℃, taking out after drying, and finishing granules;
q5, adding magnesium stearate and 10% of sweet orange powder essence, mixing, and tabletting;
q6, screening, inspecting the finished product and packaging.
Q4, sterilizing the semi-finished product at 90-95 ℃ for 30-40 minutes, cooling to room temperature, filling and sealing in a sterile workshop to obtain the finished product.
The ginseng oyster peptide tabletted candy obtained by the invention has the characteristics of convenient preparation, easy acceptance by users, convenient carrying, storage and transportation, feasible preparation process and suitability for large-scale production, the prepared product is a tablet, the appearance is complete and smooth, the color is uniform, the tablet has better uniformity and higher dissolution rate, and simultaneously compared with the existing production process, the service life of a punch of each tablet press is prolonged by 6 months under the same yield, and the production cost of an enterprise is reduced.
Detailed Description
The technical solutions of the present invention are described clearly and completely below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A dietetic composition for preventing and regulating physiological function imbalance of male is prepared from the following raw materials (by weight 1 KG),
25% of lactose, 5% of oyster peptide, 3% of L-arginine, 2% of ginseng powder, 10% of wolfberry fruit powder, 2% of cordyceps militaris powder, 2% of rhizoma polygonati, 0.2% of thermophilic lactic acid bacillus agent, 0.1% of bifidobacterium agent and 0.3% of thermophilic streptococcus agent.
The manufacturing steps are as follows:
q1, mixing Concha Ostreae peptide, L-arginine, Ginseng radix powder, fructus Lycii powder, Cordyceps powder, and rhizoma Polygonati powder to obtain mixture;
q2, lactose adding purified water to dissolve, adding thermophilic lactobacillus, bifidobacterium and streptococcus in 35 deg.C environment, fermenting under sealed condition for 1 month to obtain fermented mixture with pH of 3, adding the mixture, and making into soft material with proper humidity;
q3, pressing the soft material through a 14-mesh screen to prepare wet granules;
q4, preparing wet granules, drying at 70 ℃, taking out after drying, and finishing granules;
q5, adding magnesium stearate and 10% of sweet orange powder essence, mixing, and tabletting;
q6, screening, inspecting the finished product and packaging.
Q4, sterilizing the semi-finished product at 90 ℃ for 35 minutes, cooling to room temperature, filling and sealing in an aseptic workshop to obtain the finished product of deer blood sea cucumber tablet candy with the specification of 2mg per tablet.
And (3) testing:
1. the prepared ginseng oyster peptide tabletting candy tablet is selected from 100 volunteers, male tests show that the volunteers have symptoms of impaired vision, alopecia, sexual function erectile dysfunction, reduced motor ability, easy fatigue and the like in different degrees through detection, after the tablet is used for 3 months, the tablet is taken for 3 times every day for 6 tablets, each tablet is 2mg, after 3 months, the symptoms are obviously relieved, the volunteers show strong movement, the sexual function is obviously improved, and the alopecia and the impaired vision are improved.
2. For the quality verification of the tabletting and plain tablets, the verification method comprises the following steps: tabletting according to the specified parameters, sampling and detecting.
The sampling method comprises the following steps: randomly taking 10 tablets every 15 minutes to measure the total weight; randomly taking 20 plain tablets by each tablet press every 1 hour to detect the characters, the appearance, the friability and the weight difference; the main pressure of the tablet press was checked every 1 hour.
Acceptance criteria:
A. the characteristics are as follows: the product is white or quasi-white tablet.
B. Appearance: should be complete, smooth and uniform in color.
C. Friability: taking 10 tablets of the product, checking according to standard operation procedure of tablet friability inspection (SOP-QC-0032), wherein the weight loss reduction amount is not over 0.9%, and no fracture, crack or crushed tablet is detected.
D. Weight difference: 20 tablets of the test sample are taken and tested according to standard operating procedure of tablet weight difference checking method (SOP-QC-0001), the limit of the weight difference is +/-4.0 percent of the average tablet weight, the number exceeding the limit of the weight difference is not more than 2 tablets, and the number exceeding the limit of 1 tablet is not 1 time.
E. Material balance: 98.5-100.0% and yield not less than 98.0%.
F. No obvious dust flying in the operation process and no fragments in the turnover process of the plain film.
And (4) verification result: three batches of tabletting processes in the verification production are checked according to the method and the standard preset in the verification scheme, and the result shows that: the tablet machine performs tabletting according to the parameters specified by the technical specification, and the main pressure of the left and right pressing wheels is more than 60KN in the tabletting process; taking 20 plain tablets at intervals of 60 minutes randomly to measure the weight of each tablet, wherein the examination record shows that the character, appearance, weight difference and friability of the plain tablets all meet the requirements, the material balance rate is 98.5-100.0%, and the yield is more than or equal to 98.0%; no obvious dust flying in the operation process, and feasible tabletting process.
3. And (3) tabletting long-term test, namely, after 6 months of test under long-term conditions, the properties and the friability content of three batches of samples continuously produced by the production method are not obviously changed and all meet the specification of quality standard.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Abstract of the specification
The invention provides a dietotherapy composition for preventing and regulating physiological function imbalance of men, which is prepared from the following raw materials in parts by weight: 18 to 30 percent of lactose, 3 to 8 percent of oyster peptide, 1 to 4 percent of L-arginine, 1 to 3 percent of ginseng powder, 8 to 15 percent of male silkworm chrysalis peptide powder, 1 to 3 percent of cordyceps militaris powder, 1 to 3 percent of yellow refined powder, 1 to 3 percent of medlar powder, 0.1 to 0.3 percent of thermophilic lactic acid bacillus agent, 0.1 to 0.3 percent of bifidobacterium agent and 0.1 to 0.3 percent of thermophilic streptococcus agent; the ginseng oyster peptide tabletted candy obtained by the invention has the characteristics of convenient preparation, easy acceptance by users, convenient carrying, storage and transportation, feasible preparation process and suitability for large-scale production, the prepared product is a tablet, the appearance is complete and smooth, the color is uniform, the tablet has better uniformity and higher dissolution rate, and simultaneously compared with the existing production process, the service life of a punch of each tablet press is prolonged by 6 months under the same yield, and the production cost of an enterprise is reduced.
Claims (4)
1. (1) a dietetic composition for preventing and regulating physiological function imbalance of men, which is characterized in that: is prepared from the following raw materials in percentage by weight: 18 to 30 percent of lactose, 3 to 8 percent of oyster peptide, 1 to 4 percent of L-arginine, 1 to 3 percent of ginseng powder, 8 to 15 percent of male silkworm chrysalis peptide powder, 1 to 3 percent of cordyceps militaris powder, 1 to 3 percent of yellow refined powder, 1 to 3 percent of medlar powder, 0.1 to 0.3 percent of thermophilic lactic acid bacillus agent, 0.1 to 0.3 percent of bifidobacterium agent and 0.1 to 0.3 percent of thermophilic streptococcus agent.
The manufacturing steps are as follows (2):
q1, mixing Concha Ostreae peptide, L-arginine, Ginseng radix powder, fructus Lycii powder, Cordyceps powder, and rhizoma Polygonati powder to obtain mixture;
q2 and lactose are dissolved in purified water, thermophilic lactobacillus, bifidobacterium and streptococcus are added in the environment of 30-36 ℃, the mixture is fermented in a sealed way for 1 month, the PH value of the fermented mixture is 3-3.5, and the mixture is added to prepare soft material with proper humidity;
q3, pressing the soft material through a 14-mesh screen to prepare wet granules;
q4, preparing wet granules, drying at 70 ℃, taking out after drying, and finishing granules;
q5, adding magnesium stearate and 10% of sweet orange powder essence, mixing, and tabletting;
q6, screening, inspecting the finished product and packaging.
And Q4, sterilizing the semi-finished product at 90-95 ℃ for 30-40 minutes, cooling to room temperature, filling and sealing in a sterile workshop to obtain the finished product.
4. The dietetic composition for the prevention and regulation of physiological imbalance in men according to claim 1, wherein the dietary composition comprises: 25% of lactose, 5% of oyster peptide, 3% of L-arginine, 2% of ginseng powder, 10% of wolfberry fruit powder, 2% of cordyceps militaris powder, 2% of rhizoma polygonati, 0.2% of thermophilic lactic acid bacillus agent, 0.1% of bifidobacterium agent and 0.3% of thermophilic streptococcus agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010691077.3A CN113940422A (en) | 2020-07-17 | 2020-07-17 | Dietetic composition for preventing and regulating physiological function imbalance of men |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010691077.3A CN113940422A (en) | 2020-07-17 | 2020-07-17 | Dietetic composition for preventing and regulating physiological function imbalance of men |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113940422A true CN113940422A (en) | 2022-01-18 |
Family
ID=79327052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010691077.3A Withdrawn CN113940422A (en) | 2020-07-17 | 2020-07-17 | Dietetic composition for preventing and regulating physiological function imbalance of men |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113940422A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115381105A (en) * | 2022-08-02 | 2022-11-25 | 浙江莫干湖健康科技有限公司 | Low-sugar functional food with peptide as raw material and preparation method thereof |
-
2020
- 2020-07-17 CN CN202010691077.3A patent/CN113940422A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115381105A (en) * | 2022-08-02 | 2022-11-25 | 浙江莫干湖健康科技有限公司 | Low-sugar functional food with peptide as raw material and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105707875B (en) | A kind of red-black Fructus Lycii buccal tablet and preparation method thereof | |
CN102791849A (en) | Lactic acid bacterium-containing preparation | |
CN109122854B (en) | Milk-based snack rich in mango peel dietary fiber and preparation method thereof | |
CN111543536A (en) | Rose and hawthorn soft sweets and preparation method thereof | |
CN113940422A (en) | Dietetic composition for preventing and regulating physiological function imbalance of men | |
CN110050923A (en) | A kind of dendrobium nobile fermented beverage | |
CN108271846A (en) | A kind of mulberry leaf biscuit and process of preparing | |
CN107594442A (en) | A kind of purple potato jelly processing method | |
CN110897029A (en) | Animal and plant polypeptide tablet candy and preparation method thereof | |
CN110916028A (en) | Noni composite enzyme fruit juice and preparation method thereof | |
CN114097960A (en) | Bird's nest polypeptide beverage | |
CN101878815B (en) | Production method of donkey-hide gelatin small peptide Chinese date yoghourt | |
CN103431466A (en) | Ginseng solid beverage and preparation method thereof | |
Bornet et al. | Pasta cooking time: influence on starch digestion and plasma glucose and insulin responses in healthy subjects | |
CN110679710A (en) | Dietetic composition for preventing and regulating physiological function imbalance of men | |
CN108310258A (en) | A kind of Medicated Leaven composition and preparation method thereof | |
KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
CN110663941A (en) | Composition for preventing and conditioning male hormone hyposecretion | |
CN106490410A (en) | A kind of coconut palm Water-Electrolyte fluid infusion compositionss and preparation method thereof | |
CN109549044A (en) | A kind of probiotic beverage and preparation method thereof | |
CN104223086A (en) | Composite dendrobium huoshanense lozenge and preparation method thereof | |
CN105054208B (en) | The method that sugar grass solid beverage is prepared using permanent cold fermentation method | |
CN113951323A (en) | Tooth-protecting freeze-dried milk block and preparation method thereof | |
CN113854354A (en) | Preparation method of low-lactose dairy product rich in honey pomelo fiber | |
CN111436494A (en) | Yoghourt capable of relieving female climacteric symptoms and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220118 |